Universita Campus Bio Medico Di Roma
About Universita Campus Bio Medico Di Roma
Università Campus Bio-Medico di Roma is a for-profit college situated in Trigoria, founded in 1993 and promoted by the Beatus Alvaro del Portillo, according to the principles of the Catholic prelature of the Opus Dei.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Campus Bio-Medico University
24
Janssen Research & Development, LLC
7
Celgene
4
EMD Serono Research & Development Institute, Inc.
3
European Organisation for Research and Treatment of Cancer - EORTC
3
Italfarmaco
3
Italian Sarcoma Group
3
Biogen
2
Deciphera Pharmaceuticals LLC
2
Gilead Sciences
2
Gruppo Oncologico del Nord-Ovest
2
Clinical Trials at Universita Campus Bio Medico Di Roma
During the past decade, Universita Campus Bio Medico Di Roma conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 17 clinical trials were completed, i.e. on
average, 27% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 5 clinical trials were completed. i.e. 22.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer
1998-09-01
Completed
704
Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia
2002-09-01
2012-02-01
Completed
472
Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
2004-06-01
Unknown status
279
Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment
2007-03-01
2009-01-01
Completed
48
Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia
2004-10-01
2014-03-01
Completed
470
Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas.
2010-10-01
2016-05-01
Completed
69
Efficacy Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Patients
2005-09-01
2012-01-01
Completed
457
Mesalazine Therapy in Patients With Irritable Bowel Syndrome
2007-12-01
2012-07-01
Completed
187
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Universita Campus Bio Medico Di Roma" #1 sponsor was "Campus Bio-Medico University" with 24 trials, followed by "Janssen Research & Development, LLC" with 7 trials
sponsored, "Celgene" with 4 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 3 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC"
with 3 trials sponsored. Other sponsors include 51 different institutions and
companies that sponsored additional 50 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Universita Campus Bio Medico Di Roma"
#1 collaborator was "Campus Bio-Medico University" with 3 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Center for Outcomes Research and Clinical Epidemiology, Italy" with 2 trials as a collaborator, "Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico" with 2 trials as a collaborator and "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were
collaborators in the rest 26 trials.
Clinical Trials Conditions at Universita Campus Bio Medico Di Roma
According to Clinical.Site data, the most researched conditions in "Universita Campus Bio Medico Di Roma" are
"Crohn Disease" (4 trials), "Crohn's Disease" (4 trials), "Leukemia" (3 trials), "Metastatic Colorectal Cancer" (3 trials) and "Type 1 Diabetes" (3 trials). Many other conditions were trialed in "Universita Campus Bio Medico Di Roma" in a lesser frequency.
Clinical Trials Intervention Types at Universita Campus Bio Medico Di Roma
Most popular intervention types in "Universita Campus Bio Medico Di Roma" are "Drug" (69 trials), "Other" (18 trials), "Procedure" (10 trials), "Biological" (6 trials) and "Device" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (20 trials), "Cisplatin" (4 trials), "Docetaxel" (3 trials), "GED-0301" (3 trials) and "Gemcitabine" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Universita Campus Bio Medico Di Roma
The vast majority of trials in "Universita Campus Bio Medico Di Roma" are
81 trials for "All" genders, 15 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Universita Campus Bio Medico Di Roma
Currently, there are NaN active trials in "Universita Campus Bio Medico Di Roma".
undefined are not yet recruiting,
23 are recruiting,
9 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 43 completed trials in Universita Campus Bio Medico Di Roma,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Universita Campus Bio Medico Di Roma, 3 "Phase 1"
clinical trials were conducted, 36 "Phase 2" clinical
trials and 35 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 13 trials that are defined as “Not Applicable".